Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX
12 août 2024 16h03 HE
|
Stereotaxis, Inc.
Stereotaxis announced it has received CE mark & submitted a 510(k) application for its next-generation, semi-mobile robotic system, GenesisX.
U.S. Reprocessed Medical Devices Market Report 2024-2030: Third-party Reprocessing, In-house Reprocessing Size, Share & Trends Analysis - Increasing Emphasis on Costs Cutting
08 août 2024 11h10 HE
|
Research and Markets
Dublin, Aug. 08, 2024 (GLOBE NEWSWIRE) -- The "U.S. Reprocessed Medical Devices Market Size, Share & Trends Analysis Report by Product Type (Cardiovascular), Type (Third-party Reprocessing,...
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
31 juil. 2024 09h45 HE
|
BioSig Technologies, Inc.
Los Angeles, July 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or “Company”), a medical technology company delivering unprecedented accuracy and precision to...
Global Left Atrial Appendage Closure Devices Market (2024-2034) to Witness 20.71% CAGR - Next-Gen LAAC Devices Revolutionizing Safety, Efficacy, and Accessibility in Cardiac Care
28 mai 2024 07h28 HE
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Global Left Atrial Appendage Closure Devices Market" report has been added to ResearchAndMarkets.com's offering.The global left atrial appendage...
Global Interventional Cardiology Devices Market Projected to Reach $21.9 Billion by 2030
08 avr. 2024 04h02 HE
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "Global Interventional Cardiology Devices Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals & Clinics, Ambulatory...
Global Leadless Pacemakers Market Projected to Surpass $827.7 Million by 2030 with Notable Industry Advancements
04 avr. 2024 11h45 HE
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Leadless Pacemakers Market Size, Share & Industry Trends Analysis Report By Type (Micra Transcatheter Pacing System, and Others), By...
BioSig Announces Reduction of its Workforce
20 févr. 2024 10h00 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) -- -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company, today announced that it has terminated a...
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
06 févr. 2024 08h30 HE
|
BioSig Technologies, Inc.
Westport, CT, Feb. 06, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company committed to delivering unprecedented accuracy and...
Active Implantable Medical Devices Market Set to Surge to US$45.686 Billion by 2028 Amid Advances in Technology and Aging Population Needs
05 févr. 2024 04h03 HE
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Active Implantable Medical Devices (AIMD) Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering. This...
BioSig Announces Reverse Stock Split
31 janv. 2024 11h15 HE
|
BioSig Technologies, Inc.
Westport, CT, Jan. 31, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company committed to delivering unprecedented accuracy and...